🇺🇸 FDA
Patent

US 8436187

1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8436187 (1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/06, A61P11/08